PGBL inhibits the RAW 264.7 cells to express inflammatory factor

Area of Science:

• Immunology
• Pharmacology
• Natural Products

Background:

• Polysaccharides derived from Ginkgo biloba leaf (PGBL) exhibit anti-inflammatory properties.
• The precise mechanisms underlying PGBL's immunomodulatory effects remain unclear.
• RAW264.7 macrophage cells are a relevant model for studying immune responses.

Purpose of the Study:

• To investigate the immunomodulatory effects of PGBL on RAW264.7 cells.
• To elucidate the mechanism by which PGBL affects inflammatory signaling pathways.
• To explore the potential applications of PGBL in managing inflammatory and immune diseases.

Main Methods:

• RAW264.7 cells were treated with lipopolysaccharide (LPS) to induce inflammation.
• PGBL treatment was applied to assess its effect on LPS-induced responses.
• Key inflammatory markers including TNF-α, IL-6, and NF-κB translocation were analyzed at protein and mRNA levels.

Main Results:

• PGBL treatment significantly repressed the LPS-induced expression of TNF-α and IL-6 at both protein and mRNA levels.
• PGBL markedly inhibited the translocation of nuclear factor-kappa B (NF-κB) to the nucleus.
• These findings indicate that PGBL reduces the sensitivity of monocytes to LPS.

Conclusions:

• PGBL possesses significant immunomodulatory capabilities, acting as an anti-inflammatory agent.
• The mechanism involves the inhibition of NF-κB signaling, thereby reducing pro-inflammatory cytokine production.
• PGBL demonstrates potential therapeutic applications for systemic inflammation and immune-related disorders.